ProofReading · European doctoral network for proofreading the proteome
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2027-01-01 → 2030-12-31
- Финансиране от ЕС
- 3 345 728 €
- Участници
- 22
- Схема
- HORIZON-TMA-MSCA-DN
Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.
Накратко на български
Целево разграждане на протеини използва специални молекули, за да насочи клетъчния механизъм за почистване към конкретни вредни протеини. Това помага за разработването на методи за справяне с рак, инфекции, възпаления и редки заболявания.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
Targeted Protein Degradation (TPD), an innovative strategy to redirect the cellular degradation machinery towards the elimination of disease-relevant proteins, has attracted enormous attention from researchers, industry and clinicians. TPD is based on the capacity of a small molecule, the degrader, to re-route the ubiquitination machinery towards a selected protein of interest to trigger its ubiquitination and degradation by the Ubiquitin Proteasomal System, via its interaction with specific E3 ubiquitin ligases.ProofReading will bring together a diverse community, assembling the necessary multidisciplinary expertise to develop novel TPD approaches applicable to various cellular and disease contexts, facilitating the generation of degraders. ProofReading will establish an interdisciplinary, intersectoral and international research programme to drive the development of tools, degraders and innovative strategies aimed at eliminating targets involved in cancer, infection, inflammation and rare diseases.The network comprises 10 universities, 4 research centres and 8 innovative companies, which will provide state-of-the-art training for the recruited Doctoral Candidates (DCs). This is the only doctoral network related to proteome proofreading by using TPD that combines the knowledge in all disciplines, ranging from life to physical sciences, required to develop a degrader. Interdisciplinary and intersectoral secondments will expose the DCs to different working environments. We will organize 5 hands-on research workshops on central methodological and technical aspects of TPD and 7 courses on transferable skills, of primary importance for increasing the employability of the DCs. We will also address the important issue of mental health and well-being in science.ProofReading will train 11 researchers with specific knowledge in the cutting-edge technology of TPD, which will contribute to the generation of future drugs to treat diseases.
Оригинален текст от CORDIS (на английски).
Участници
- ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS · DERIO VIZCAYAКоординаторИспания
- ASTRAZENECA UK LIMITED · CAMBRIDGEОбединеното кралство
- ATLAS MOLECULAR PHARMA SL · DerioИспания
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS · ParisФранция
- DYNAMIC BIOSENSORS GMBH · MUNICHГермания
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE · LausanneШвейцария
- FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH · WienАвстрия
- FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS · BadalonaИспания
- HYBRIGENICS SERVICES · Evry-CourcouronnesФранция
- JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN · Frankfurt Am MainГермания
- NORARTE VISUAL SCIENCE SL · AbadiñoНиво градИспания
- Oniria Therapeutics SL · BarcelonaНиво градИспания
- PHILIPPS UNIVERSITAET MARBURG · MarburgГермания
- Proxygen GmbH · ViennaНиво градАвстрия
- Sofia Maria Facal BelliИспания
- TECHNISCHE UNIVERSITAET DRESDEN · DresdenГермания
- UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA · LeioaИспания
- UNIVERSITA DEGLI STUDI DI MILANO · MilanoИталия
- UNIVERSITAT DE BARCELONA · BarcelonaИспания
- UNIVERSITAT WIEN · WienАвстрия
- UNIVERSITE DE TOULOUSE · ToulouseФранция
- VRIJE UNIVERSITEIT BRUSSEL · Bruxelles / BrusselБелгия
Връзки
Данни: CORDIS, © Европейски съюз
